m+Medelevator.RU
← Поиск публикаций
Journal of Indian Society of Periodontology · 2024

Management of mucogingival defect following excision of multiple gingival squamous cell papillomas using VISTA - A case report with 24 months follow-up.

Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Shetty Sharath K, Kulloli Anita, Gopalakrishnan Dharmarajan, Kheur Supriya, Zadeh Homayoun H

Аннотация

Oral squamous cell papilloma is a benign proliferation of the stratified squamous epithelium, associated with the human papillomavirus (HPV). The clinical manifestation includes papillary or verrucous exophytic mass. Complete excision of the lesion, including normal margins, followed by histopathological examination is the treatment of choice. However, mucogingival defect may be observed after excision of the lesion, requiring management by perioplastic surgery. In this report, a 27-year-old male with an unremarkable medical history reported multiple sessile growths on his gingiva. The masses were located in the left maxillary canine and mandibular premolar regions, exhibiting finger-like projections with white and pink surface color. The lesions were removed by excisional biopsy and submitted for histopathologic examination. After excision, type II noncervical carious lesions (NCCLs) became exposed that were previously covered by papilloma outgrowths. Miller's class I/RT1 recession defects that were present were managed by vestibular incision subperiosteal tunnel access (VISTA) in concert with amnion-chorion membrane (ACM) with 24 months' follow-up. In this case report, mucogingival defects that resulted after the excision of multiple gingival squamous cell papillomas were managed by VISTA in concert with ACM. A favorable outcome was achieved that was stable during the 24-month follow-up.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты